HMGB1 and colorectal carcinoma: Although, it was not significantly associated with clinic-pathological features in our CRC samples (Fig. 5b), we still observed a consistent mRNA and protein over-expression of HMGB1 (Figs. 1, 5), as well as significant correlation between mRNA and CNV gains (Fig. 3b).